IDEXX Laboratories Inc
NASDAQ:IDXX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
US |
|
Bastogi SpA
MIL:B
|
IT |
|
I
|
Insperity Inc
F:ASF
|
US |
Intrinsic Value
The intrinsic value of IDEXX Laboratories Inc (IDXX) under the Base Case is 549.95 USD per share.
Compared with the current market price of 704.26 USD, the stock appears
Overvalued by 22% .
The intrinsic value is calculated using the DCF method. The model assumes IDEXX largely repeats its recent record: revenue grows 9.5% a year over the next five years, with net margin near last year's 25%. If revenue growth matched its five-year pace of 9.7%, the estimate would be about $644.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What IDEXX Laboratories Does
IDEXX Laboratories makes diagnostic tools and software for veterinarians, animal clinics, farms, and water testing labs. Its core products help customers run blood, urine, fecal, and other tests on-site or in reference labs, so animal health problems can be found and treated faster. It also sells imaging and practice-management software that helps veterinary clinics manage records, appointments, and workflows.
- Headquarters
- United States of America US
- Employees
- 11 000
- IPO date
- Jun 21, 1991
IDEXX Laboratories has a wide economic moat
Replacing IDEXX's connected testing machines, software and laboratory services takes money, staff training and changes to daily routines, making it difficult for rivals to win established customers. Patented testing technology and approved test methods also make parts of its offering harder to copy.
Read the full moat analysis
Revenue & Expenses Breakdown
IDEXX Laboratories Inc
Earnings Waterfall
IDEXX Laboratories Inc
The intrinsic value for IDEXX Laboratories Inc (IDXX) under the Base Case is 549.95 USD.
Compared with the current market price of 704.26 USD, the stock appears Overvalued by 22% .
